Literature DB >> 27000306

Decreased gray matter volume is associated with the subtypes of psychotic symptoms in patients with antipsychotic-naïve mild or moderate Alzheimer's disease: A voxel-based morphometry study.

Young-Min Lee1, Young-In Chung2, Je-Min Park1, Byung-Dae Lee1, Eunsoo Moon1, Hee-Jeong Jeong1, Ji-Hoon Kim3, Hak-Jin Kim4, Chi-Woong Mun5, Tae-Hyung Kim5, Young-Hoon Kim6, Eun-Joo Kim7.   

Abstract

The purpose of this study was to investigate the association between brain regional gray matter volume and two subtypes of psychotic symptoms, namely paranoid and misidentification subtypes, in antipsychotic-naïve mild or moderate Alzheimer's disease (AD) patients. Forty AD patients with psychotic symptoms and 25 AD patients without psychotic symptoms were assessed for cognitive and functional impairment. Presence and subtype of psychotic symptoms were assessed by using the delusion and hallucination subscale of the Korean Neuropsychiatric Inventory (K-NPI). Structural MRI images were acquired on a 3 T scanner, and were analyzed using voxel-based morphometry (VBM) for automated analysis. The misidentification subtype is associated with more severe gray matter atrophy, and paranoid subtype is associated with less severe gray matter atrophy compared to non-psychosis group. These results suggest that the misidentification, the paranoid subtype and the non-psychosis group have a distinct neural correlation.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Alzheimer's disease; The gray matter volumes; The subtypes of psychotic symptoms

Mesh:

Year:  2015        PMID: 27000306     DOI: 10.1016/j.pscychresns.2015.12.002

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  4 in total

1.  Misidentification Subtype of Alzheimer's Disease Psychosis Predicts a Faster Cognitive Decline.

Authors:  Fabrizia D'Antonio; Suzanne Reeves; Yucheng Sheng; Emma McLachlan; Carlo de Lena; Robert Howard; Julie Bertrand
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-03-15

2.  Meta-analytic Evidence for the Plurality of Mechanisms in Transdiagnostic Structural MRI Studies of Hallucination Status.

Authors:  Colleen P E Rollins; Jane R Garrison; Jon S Simons; James B Rowe; Claire O'Callaghan; Graham K Murray; John Suckling
Journal:  EClinicalMedicine       Date:  2019-02-21

3.  Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets.

Authors:  Ryan A Neff; Minghui Wang; Sezen Vatansever; Lei Guo; Chen Ming; Qian Wang; Erming Wang; Emrin Horgusluoglu-Moloch; Won-Min Song; Aiqun Li; Emilie L Castranio; Julia Tcw; Lap Ho; Alison Goate; Valentina Fossati; Scott Noggle; Sam Gandy; Michelle E Ehrlich; Pavel Katsel; Eric Schadt; Dongming Cai; Kristen J Brennand; Vahram Haroutunian; Bin Zhang
Journal:  Sci Adv       Date:  2021-01-06       Impact factor: 14.957

4.  Meta-analysis of structural and functional brain abnormalities in schizophrenia with persistent negative symptoms using activation likelihood estimation.

Authors:  Tingting Zhu; Zixu Wang; Chao Zhou; Xinyu Fang; Chengbing Huang; Chunming Xie; Honglin Ge; Zheng Yan; Xiangrong Zhang; Jiu Chen
Journal:  Front Psychiatry       Date:  2022-09-27       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.